Riso Pharmaceuticals International
Bioadvantex
Urixin
Silexin
Biolyse
Paclitaxel
BioSyent Inc.
FeraMAX
Feldan
Glenwood
Helsinn
Gelclair
Klean-Prep
Nasaleze Ltd.
Nasaleze
Omega laboratories
Pamidronate
PISA
Serral Laboratories
Stella Pharmaceutical Canada Inc.
Kolik-Gripe Water
Unigene
Fortical
 
Urixin

 

urixin
What is URIXIN?

URIXIN® has been formulated to help to relieve the urological symptoms associated with Benign Prostatic Hyperplasia (BPH). URIXIN contains standardized saw palmetto with 85-95% sterols and fatty acids (the highest extract of standardized saw palmetto available) and purified plant phytosterols with beta-sitosterols.

What is BPH?

BPH is a non-cancerous enlargement of the prostate. Some common symptoms of BPH include frequent urination, excessive night-time urination, difficulty starting to urinate, or diminished flow.

Why URIXIN?
  • To relieve or ameliorate the symptoms associated with Benign Prostatic Hyperplasia (BPH).
  • Trusted and recommended by leading Urologists.
  • Produced under strict quality control.
  • Dosage based on the most recent scientific research findings.
For optimal results, URIXIN should be taken for a minimum period of 3 continuous months, or, as recommended by your physician.

More Information ...

 
 

Riso Pharma Tech is a Canadian-based specialty pharmaceutical company focused on in-licensing late-stage and approved molecules for marketing and sales in Canada, certain European Union countries, Latin America, and the Middle East.

 

From large multi-national pharmaceutical companies to small biotechs, Riso's license deals have yielded successful product launches in its territories. Five regional offices and over 360 employees worldwide enable Riso to extend the reach of our partner companies' products.

 

With an extensive track record of greater than 10+ years marketing and sales success in its territories, and thanks to Riso's financial strength, Riso is aggressively pursuing new in-licensing opportunities across several therapeutic areas: oncology, supportive care, neurology, endocrinology and women's health.